Reed Elsevier Rating Reiterated by Societe Generale (REL)
Reed Elsevier (LON: REL)‘s stock had its “buy” rating restated by equities researchers at Societe Generale in a report issued on Friday. They currently have a $12.51 (825 GBX) target price on the stock.
Reed Elsevier opened at 714.50 on Friday. Reed Elsevier has a 1-year low of GBX 466.10 and a 1-year high of GBX 725.00. The stock’s 50-day moving average is currently GBX 599.8. The company’s market cap is £8.603 billion.
Several other analysts have also recently commented on the stock. Analysts at Numis Securities Ltd reiterated an “add” rating on shares of Reed Elsevier in a research note to investors on Thursday. They now have a $12.15 price target on the stock. Separately, analysts at Investec reiterated a “buy” rating on shares of Reed Elsevier in a research note to investors on Thursday. They now have a $11.83 price target on the stock. Finally, analysts at JPMorgan Chase reiterated an “overweight” rating on shares of Reed Elsevier in a research note to investors on Wednesday.
Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.